International Psoriasis Council

Advancing Knowledge. Improving Care.

A man with light skin, short light brown hair, and blue eyes is smiling at the camera against a dark blue background. He is wearing a light-colored collared shirt.

John Edmund

Armourer Common

,

PhD

Newcastle University
Newcastle upon Tyne
,
United Kingdom
Professor John Common is a biomedical researcher specializing in inflammatory skin diseases, skin barrier biology, and the skin microbiome. A professor of cutaneous inflammation and microbiome, he holds a joint academic appointment at Newcastle University (United Kingdom) and A*STAR Skin Research Labs (Singapore), where he leads translational programs integrating host-microbe-immune interactions in skin health and disease.

His work bridges fundamental biology with clinical relevance, spanning diverse areas such as atopic dermatitis, acne vulgaris, and ichthyosis. He employs systems biology approaches, including metagenomics, metatranscriptomics, and 3D skin models, to uncover mechanisms driving disease heterogeneity and therapeutic response. He has contributed to international consortia and partnered with industry to investigate mRNA-based skin therapeutics.

Professor Common has a longstanding interest in multiethnic skin research and is committed to advancing personalized dermatology through precision medicine and microbiome engineering.
Last Updated:
05/07/2026

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026